150 related articles for article (PubMed ID: 29701086)
1. Longer duration of symptoms at the time of presentation is not associated with worse survival in primary bone sarcoma.
Lawrenz JM; Styron JF; Parry M; Grimer RJ; Mesko NW
Bone Joint J; 2018 May; 100-B(5):652-661. PubMed ID: 29701086
[TBL] [Abstract][Full Text] [Related]
2. Delay in the diagnosis and treatment of primary bone sarcoma of the pelvis.
Wurtz LD; Peabody TD; Simon MA
J Bone Joint Surg Am; 1999 Mar; 81(3):317-25. PubMed ID: 10199269
[TBL] [Abstract][Full Text] [Related]
3. Does length of symptoms before diagnosis of sarcoma affect patient survival?
Rougraff BT; Davis K; Lawrence J
Clin Orthop Relat Res; 2007 Sep; 462():181-9. PubMed ID: 17534186
[TBL] [Abstract][Full Text] [Related]
4. Retrospective analysis of the impact of symptom duration on prognosis in soft tissue sarcoma.
Saithna A; Pynsent PB; Grimer RJ
Int Orthop; 2008 Jun; 32(3):381-4. PubMed ID: 17377790
[TBL] [Abstract][Full Text] [Related]
5. Homogenous and Heterogenous Prognostic Factors for Patients with Bone Sarcoma.
Xu G; Wu H; Xu Y; Zhang Y; Lin F; Baklaushev VP; Chekhonin VP; Peltzer K; Wang X; Mao M; Wang G; Cui P; Zhang C
Orthop Surg; 2021 Feb; 13(1):134-144. PubMed ID: 33305494
[TBL] [Abstract][Full Text] [Related]
6. Survival in Mesenchymal Chondrosarcoma Varies Based on Age and Tumor Location: A Survival Analysis of the SEER Database.
Schneiderman BA; Kliethermes SA; Nystrom LM
Clin Orthop Relat Res; 2017 Mar; 475(3):799-805. PubMed ID: 26975384
[TBL] [Abstract][Full Text] [Related]
7. One-year mortality in patients with bone and soft tissue sarcomas as an indicator of delay in presentation.
Nandra R; Hwang N; Matharu GS; Reddy K; Grimer R
Ann R Coll Surg Engl; 2015 Sep; 97(6):425-33. PubMed ID: 26274756
[TBL] [Abstract][Full Text] [Related]
8. Survival of patients with malignant primary osseous spinal neoplasms: results from the Surveillance, Epidemiology, and End Results (SEER) database from 1973 to 2003.
Mukherjee D; Chaichana KL; Gokaslan ZL; Aaronson O; Cheng JS; McGirt MJ
J Neurosurg Spine; 2011 Feb; 14(2):143-50. PubMed ID: 21184634
[TBL] [Abstract][Full Text] [Related]
9. Evaluation of Absolute Lymphocyte Count at Diagnosis and Mortality Among Patients With Localized Bone or Soft Tissue Sarcoma.
Brewster R; Purington N; Henry S; Wood D; Ganjoo K; Bui N
JAMA Netw Open; 2021 Mar; 4(3):e210845. PubMed ID: 33666664
[TBL] [Abstract][Full Text] [Related]
10. Referral patterns, treatment and outcome of high-grade malignant bone sarcoma in Scandinavia--SSG Central Register 25 years' experience.
Zaikova O; Sundby Hall K; Styring E; Eriksson M; Trovik CS; Bergh P; Bjerkehagen B; Skorpil M; Weedon-Fekjaer H; Bauer HC
J Surg Oncol; 2015 Dec; 112(8):853-60. PubMed ID: 26482729
[TBL] [Abstract][Full Text] [Related]
11. Incidence, treatment and survival of paediatric patients with bone sarcomas in Finland from 1991 to 2005.
Serlo J; Tarkkanen M; Sampo M; Vettenranta K; Riikonen P; Helenius I
Acta Paediatr; 2015 Jul; 104(7):738-45. PubMed ID: 25721807
[TBL] [Abstract][Full Text] [Related]
12. Long-term Outcomes and Complications in Pediatric Ewing Sarcoma.
Hamilton SN; Carlson R; Hasan H; Rassekh SR; Goddard K
Am J Clin Oncol; 2017 Aug; 40(4):423-428. PubMed ID: 25599318
[TBL] [Abstract][Full Text] [Related]
13. Prognostic factors affecting survival in metastatic soft tissue sarcoma: an analysis of 110 patients.
Iqbal N; Shukla NK; Deo SV; Agarwala S; Sharma DN; Sharma MC; Bakhshi S
Clin Transl Oncol; 2016 Mar; 18(3):310-6. PubMed ID: 26243399
[TBL] [Abstract][Full Text] [Related]
14. Delay in Diagnosis and Its Effect on Clinical Outcome in High-grade Sarcoma of Bone: A Referral Oncological Centre Study.
Goedhart LM; Gerbers JG; Ploegmakers JJ; Jutte PC
Orthop Surg; 2016 May; 8(2):122-8. PubMed ID: 27384720
[TBL] [Abstract][Full Text] [Related]
15. Conditional survival of pediatric, adolescent, and young adult soft tissue sarcoma and bone tumor patients.
Ou JY; Spraker-Perlman H; Dietz AC; Smits-Seemann RR; Kaul S; Kirchhoff AC
Cancer Epidemiol; 2017 Oct; 50(Pt A):150-157. PubMed ID: 28992567
[TBL] [Abstract][Full Text] [Related]
16. Can Multistate Modeling of Local Recurrence, Distant Metastasis, and Death Improve the Prediction of Outcome in Patients With Soft Tissue Sarcomas?
Posch F; Leitner L; Bergovec M; Bezan A; Stotz M; Gerger A; Pichler M; Stöger H; Liegl-Atzwanger B; Leithner A; Szkandera J
Clin Orthop Relat Res; 2017 May; 475(5):1427-1435. PubMed ID: 28083752
[TBL] [Abstract][Full Text] [Related]
17. Validation of prognostic scoring and assessment of clinical benefit for patients with bone sarcomas enrolled in phase I clinical trials.
Livingston JA; Hess KR; Naing A; Hong DS; Patel S; Benjamin RS; Ludwig JA; Conley A; Herzog CE; Anderson P; Meric-Bernstam F; Kurzrock R; Subbiah V
Oncotarget; 2016 Sep; 7(39):64421-64430. PubMed ID: 27486883
[TBL] [Abstract][Full Text] [Related]
18. Prognostic implications of PD-L1 expression in patients with soft tissue sarcoma.
Kim C; Kim EK; Jung H; Chon HJ; Han JW; Shin KH; Hu H; Kim KS; Choi YD; Kim S; Lee YH; Suh JS; Ahn JB; Chung HC; Noh SH; Rha SY; Kim SH; Kim HS
BMC Cancer; 2016 Jul; 16():434. PubMed ID: 27393385
[TBL] [Abstract][Full Text] [Related]
19. Bone versus soft-tissue sarcomas in the elderly.
Torigoe T; Terakado A; Suehara Y; Kurosawa H; Yazawa Y; Takagi T
J Orthop Surg (Hong Kong); 2010 Apr; 18(1):58-62. PubMed ID: 20427836
[TBL] [Abstract][Full Text] [Related]
20. Survival and prognostic factors at time of diagnosis in high-grade appendicular osteosarcoma: a 21 year single institution evaluation from east Denmark.
Colding-Rasmussen T; Thorn AP; Horstmann P; Rechnitzer C; Hjalgrim LL; Krarup-Hansen A; Petersen MM
Acta Oncol; 2018 Mar; 57(3):420-425. PubMed ID: 28741397
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
